Credentialing for breast lymphatic mapping: How many cases are enough?

Annals of Surgery

Volumn 229, Issue 5, 1999, Pages 723-728

  Cody III, Hiram S ^a   Hill, Arnold D K ^a   Tran, Katherine N ^a   Brennan, Murray F ^a   Borgen, Patrick I ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ADULT; AGED; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST SURGERY; CLINICAL ARTICLE; COMPETENCE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; SURGICAL TRAINING; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; CREDENTIALING; FALSE NEGATIVE REACTIONS; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PROSPECTIVE STUDIES; UNITED STATES;

EID: 0033497839     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199905000-00015     Document Type: Conference Paper

References (26)

1. Fisher B, Ravdin RG, Ausman RK, et al. Surgical adjuvant chemotherapy in cancer of the breast: results of a cooperative investigation. Ann Surg 1968; 168:337-356.
2. Bonadonna G, Valagussa P, Moliterni A, et al. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med 1995; 332:901-906.
3. Cabanas R. An approach for the treatment of penile carcinoma. Cancer 1977; 39:456-466.
4. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-399.
5. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2:335-340.
6. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-401.
7. Albertini JJ, Lyman GH. Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276:1818-1822.
8. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997; 349:1864-1867.
9. Pijpers R, Hoekstra OS, Collet GJ, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997; 38:366-368.
10. Roumen RMH, Valkenburg JGM, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997; 23:495-502.
11. Galimberti V, Zurrida S, Zucali P, Luini A. Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? Breast 1998; 7:8-10.
12. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP. Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186:275-283.
13. Krag DN, Ashikaga T, Harlow SP, Weaver DL. Development of sentinel node targeting technique in breast cancer patients. Breast J 1998; 4:67-74.
14. Offodile R, Hoh C, Barsky SH, et al. Minimally invasive breast cancer staging using lymphatic mapping with radiolabeled dextran. Cancer 1998; 82:1704-1708.
15. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998; 339:941-946.
16. Crossin JA, Johnson AC, Stewart PB, Turner WW. Gamma-probeguided resection of the sentinel lymph node in breast cancer. Am Surgeon 1998; 64:666-669.
17. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lyniphadenectomy in breast cancer. J Clin Oncol 1997; 15:2345-2350.
18. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997; 3:336-340.
19. Flett MM, Going JJ, Stanton PD. Cooke TG. Sentinel node localization in patients with breast cancer. Br J Surg 1998; 85:991-993.
20. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997; 349:1668-1669.
21. O'Hea BJ, Hill ADK, El-Shirbiny A, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186:423-427.
22. Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998; 5:126-130.
23. Hill ADK, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999; 229:528-535.
24. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 3:394-401.
25. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997; 226:271-278.
26. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998; 16:2253-2260.